0001214659-20-008371.txt : 20201002
0001214659-20-008371.hdr.sgml : 20201002
20201002161506
ACCESSION NUMBER: 0001214659-20-008371
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20201002
DATE AS OF CHANGE: 20201002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARLIANT RONALD
CENTRAL INDEX KEY: 0001288093
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 201220163
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-49822.xml
PRIMARY DOCUMENT
X0306
4
2020-09-30
0001293310
HUMANIGEN, INC
HGEN
0001288093
BARLIANT RONALD
C/O HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400
BURLINGAME
CA
94010
true
false
false
false
Stock Option (Right to Buy)
10.64
2020-09-30
4
A
false
1803
8.04
A
2020-09-30
2030-09-29
Common Stock
1803
1803
D
The stock option was granted to Mr. Barliant in lieu of $14,500 of cash compensation otherwise payable to Mr. Barliant in respect of his services as a director during the third quarter of 2020.
/s/ Cameron Durrant, Attorney-In-Fact
2020-10-02